Cost savings in cancer care from the selection of effective versus ineffective initial chemotherapy.
Dickinson
K D
KD
Analytical Biosystems, Warwick, RI 02886.
Myers
T J
TJ
D000230:Adenocarcinoma / Q000191:economics; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000191:economics; D002277:Carcinoma / Q000191:economics; D002294:Carcinoma, Squamous Cell / Q000191:economics; D003362:Cost-Benefit Analysis; D005260:Female; D006258:Head and Neck Neoplasms / Q000191:economics; D006801:Humans; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000188:drug therapy / Q000191:economics*; D010051:Ovarian Neoplasms / Q000191:economics; D012004:Rectal Neoplasms / Q000191:economics; D012237:Rhode Island; D014481:United States
D000970:Antineoplastic Agents